➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Johnson and Johnson
Moodys
McKinsey
Express Scripts

Last Updated: August 14, 2020

DrugPatentWatch Database Preview

INDAPAMIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US ANDA Litigation and Generic Entry Outlook for Indapamide

A generic version of INDAPAMIDE was approved as indapamide by ANI PHARMS INC on July 27th, 1995.

  Start Trial

Drug patent expirations by year for INDAPAMIDE
Drug Prices for INDAPAMIDE

See drug prices for INDAPAMIDE

Recent Clinical Trials for INDAPAMIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shanghai Jiao Tong University School of MedicinePhase 4
ACCESS Community Health NetworkPhase 2
University of SydneyPhase 2

See all INDAPAMIDE clinical trials

Pharmacology for INDAPAMIDE
Drug ClassThiazide-like Diuretic
Physiological EffectIncreased Diuresis
Medical Subject Heading (MeSH) Categories for INDAPAMIDE

US Patents and Regulatory Information for INDAPAMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth INDAPAMIDE indapamide TABLET;ORAL 074722-001 Jun 17, 1996 AB RX No No   Start Trial   Start Trial   Start Trial
Yaopharma Co Ltd INDAPAMIDE indapamide TABLET;ORAL 074594-002 May 23, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Ani Pharms Inc INDAPAMIDE indapamide TABLET;ORAL 074498-001 Oct 31, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Ani Pharms Inc INDAPAMIDE indapamide TABLET;ORAL 074498-002 Feb 12, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan Pharms Inc INDAPAMIDE indapamide TABLET;ORAL 075105-002 Jul 23, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Mallinckrodt
Baxter
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.